Should methotrexate plus calcineurin inhibitors be considered standard of care for prophylaxis of acute graft-versus-host disease?

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Volumn 16, Issue 1 Suppl, 2010, Pages

  Storb, Rainer ^a   Antin, Joseph H ^b   Cutler, Corey ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; ENZYME INHIBITOR; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE;

ANIMAL; CONTROLLED CLINICAL TRIAL; DRUG ANTAGONISM; GRAFT VERSUS HOST REACTION; HUMAN; REVIEW;

ANIMALS; CALCINEURIN; CONTROLLED CLINICAL TRIALS AS TOPIC; ENZYME INHIBITORS; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; METHOTREXATE;

EID: 77953051955     PISSN: None     EISSN: 15236536     Source Type: Journal    
DOI: None     Document Type: Review

References (89)